Innate Pharma (IPHA)
(Real Time Quote from BATS)
$2.25 USD
0.00 (0.00%)
Updated Sep 23, 2024 01:51 PM ET
After-Market: $2.25 0.00 (0.00%) 4:10 PM ET
4-Sell of 5 4
F Value F Growth F Momentum F VGM
Brokerage Reports
0 items in cart
Innate Pharma S.A. Sponsored ADR [IPHA]
Reports for Purchase
Showing records 1 - 20 ( 31 total )
Company: Innate Pharma S.A. Sponsored ADR
Industry: Medical - Biomedical and Genetics
Key Takeaways from KOL Panels at Our Immune Cell Engager Conference
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: Innate Pharma S.A. Sponsored ADR
Industry: Medical - Biomedical and Genetics
Positive Topline Data Support Potential of Lacutamab in 3L+ MF; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: Innate Pharma S.A. Sponsored ADR
Industry: Medical - Biomedical and Genetics
MF Data Could Inform Regulatory Pathway for Lacutamab; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: Innate Pharma S.A. Sponsored ADR
Industry: Medical - Biomedical and Genetics
Preclinical Data with Novel ADC Suggests Competitive Potential; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: Innate Pharma S.A. Sponsored ADR
Industry: Medical - Biomedical and Genetics
Regulatory Pathway for Lacutamab Coming into Focus; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: Innate Pharma S.A. Sponsored ADR
Industry: Medical - Biomedical and Genetics
Strong Data in SS Support Filing of BLA For Accelerated Approval of Lacutamab; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: Innate Pharma S.A. Sponsored ADR
Industry: Medical - Biomedical and Genetics
Year-End Lacutamab Updates Under the Spotlight; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: Innate Pharma S.A. Sponsored ADR
Industry: Medical - Biomedical and Genetics
TELLOMAK Final Readout in 2H23; ANKET-Based Programs Progressing; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: Innate Pharma S.A. Sponsored ADR
Industry: Medical - Biomedical and Genetics
Tellomak Analyzed With New Lymph Node Evaluation Criteria Remains Positive; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: Innate Pharma S.A. Sponsored ADR
Industry: Medical - Biomedical and Genetics
Focus on Lacutamab Readouts in 2H23; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: Innate Pharma S.A. Sponsored ADR
Industry: Medical - Biomedical and Genetics
TELLOMAK Final Readout in 2H23; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: Innate Pharma S.A. Sponsored ADR
Industry: Medical - Biomedical and Genetics
TELLOMAK Readout at ASH; Continued Clinical Progress; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: Innate Pharma S.A. Sponsored ADR
Industry: Medical - Biomedical and Genetics
TELLOMAK Update Underscores Lacutamab''s Potential in MF; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: Research Department
Company: Innate Pharma S.A. Sponsored ADR
Industry: Medical - Biomedical and Genetics
Awaiting Pivotal Lacutamab Data 2H22; Pipeline Progressing; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: Innate Pharma S.A. Sponsored ADR
Industry: Medical - Biomedical and Genetics
Monalizumab Achieved Another Milestone; TELLOMAK Readouts on Track; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: Innate Pharma S.A. Sponsored ADR
Industry: Medical - Biomedical and Genetics
Pipeline Continues to Progress in 2022; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: Innate Pharma S.A. Sponsored ADR
Industry: Medical - Biomedical and Genetics
Positive Clinical Update on Monalizumab at ESMO-IO; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: Innate Pharma S.A. Sponsored ADR
Industry: Medical - Biomedical and Genetics
Durvalumab COAST Update Makes a Splash at ESMO
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: Innate Pharma S.A. Sponsored ADR
Industry: Medical - Biomedical and Genetics
Company: Innate Pharma S.A. Sponsored ADR
Industry: Medical - Biomedical and Genetics
Lacutamab Shows Promise in Mycosis Fungoides; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S